Mononucleosis, also called the kissing disease, is a contagious disease most often caused by the Epstein-Barr virus (EBV). It’s usually not serious but can take some time to recover.

Infectious mononucleosis (more commonly known as mono) is a disease you can catch if you get infected with certain viruses, mainly the Epstein-Barr virus (EBV). “Ninety percent of cases of ...

EBV, mono’s primary driver, is extremely common — so much so that not having been infected with EBV is much rarer than being infected by it at some point.

Mononucleosis, otherwise known as mono, glandular fever, or the “kissing disease,” is a common illness, especially among teens and college students. In this article, find out the risk factors ...

Mononucleosis, often referred to as “mono” or “the kissing disease,” is commonly associated with teenagers and young adults. This nickname arises from its primary transmission mode ...

The Epstein-Barr virus (EBV) causes most cases of mononucleosis. Is it possible to contract EBV more than once? And does that mean you can get mono twice?

EBV causes mono, the "kissing disease," and can trigger a heightened immune response in teens. Researchers think that developing a vaccine against EBV could make MS a disease of the past.

The mono virus — called Epstein-Barr virus (EBV) — infects more than 90% of people by adulthood, although it usually causes no symptoms. In some people, it can trigger infectious mononucleosis ...

It's an infection caused by a virus (the Epstein-Barr virus or EBV). Mono is very common in teens. Mononucleosis is contagious! If you've got mono, you can spread it to others.

Mononucleosis is caused by an infection with the virus known as the Epstein-Barr virus (EBV). The virus is a member of the herpes virus family that can remain latent in the body long after the ...

EBV, named for two of the researchers who discovered it, is millions of years older than SARS-CoV-2, but its prolonged effects are only just beginning to be well understood. They’re elusive in ...

“Mono Vaccines (Epstein-Barr virus) Market” from 2024-2034 with covered segments (By Age group (Adult, and Pediatrics), and Regional Forecast, 2024-2034), which provides the perfect mix of ...